Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PKCδ inhibitors(Protein kinase C delta inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
KRAS G12C mutant Non-small Cell Lung Cancer | Preclinical | CN | 30 Jun 2023 | |
KRAS mutant Colorectal Cancer | Preclinical | CN | 30 Jun 2023 | |
KRAS Mutant Pancreatic Cancer | Preclinical | CN | 30 Jun 2023 |